在ICH M10后的药理动力学试验的交叉验证不是通过/失败的标准
Marianne Scheel Fjording1, Joanne Goodman2, Chad Briscoe3
1Biolyzr, Vaerloese, DK-3500, Denmark.
Bioanalysis
|November 7, 2024
概括
ICH M10指南要求对药理动力学试验进行交叉验证,但缺乏具体的接受标准. 本指南解释了生物分析实验室如何在此进行导航,以获得可靠的数据可比性.
科学领域:
- 药理动力学 药理动力学
- 生物分析化学 生物分析化学
- 监管科学 监管科学
背景情况:
- 国际协调理事会 (ICH) M10指南制定了在药物动力学 (PK) 测定中对生物分析方法验证的全球标准.
- 交叉验证对于确保数据可比性至关重要,当在研究中或跨研究中使用多种方法或实验室时.
- 在ICH M10后的一个关键挑战是,没有特定的交叉验证验收标准,这与传统的通过/失败方法有所不同.
相关概念视频
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Pharmacokinetic Models: Comparison and Selection Criterion
46
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
46
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
399
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
399
Data Validation
146
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
146
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
70
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
70


